Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 7/20 | 0.42 |
| ▸ | JAK2 | O60674 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | CCR1 | P32246 | 2/20 | 0.41 |
| ▸ | CCR8 | P51685 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30320785 | 0.83 | NOX1 (0.44) | PTGESJAK2L3MBTL1CCR1CCR8 | |
| SCHEMBL28295235 | 0.81 | KDM4E (0.55) | PTGESL3MBTL1CCR1CCR8ALDH1A1 | |
| SCHEMBL14579767 | 0.81 | MAP4K4 (0.47) | PTGESL3MBTL1ALDH1A1MAPTKDM4E | |
| SCHEMBL28296998 | 0.80 | NOX1 (0.45) | PTGESJAK2L3MBTL1CCR1CCR8 | |
| SCHEMBL30171053 | 0.80 | MAP4K4 (0.52) | PTGESALDH1A1MAPTKDM4ENPC1 | |
| SCHEMBL5323937 | 0.80 | MAP4K4 (0.52) | PTGESALDH1A1MAPTKDM4ENPC1 | |
| SCHEMBL2291094 | 0.78 | NPC1 (0.61) | L3MBTL1ALDH1A1MAPTKDM4ENPC1 | |
| SCHEMBL31557361 | 0.78 | NPC1 (0.61) | L3MBTL1ALDH1A1MAPTKDM4ENPC1 | |
| SCHEMBL30636668 | 0.77 | NPC1 (0.53) | L3MBTL1CCR1CCR8ALDH1A1MAPT | |
| SCHEMBL10067259 | 0.77 | PTGES (0.44) | PTGESJAK2L3MBTL1CCR1CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | claimed |
| US-20040265628-A1 | Organic luminescent compounds and methods of making and using same | LG DISPLAY CO., LTD. (KP) | 2004-12-30 | — | — | US | claimed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7291404-B2 | Organic light emitting devices | LG.PHILIPS LCD CO., LTD. (KR) | 2007-11-06 | — | — | US | disclosed |
| US-20040265628-A1 | Organic luminescent compounds and methods of making and using same | LG DISPLAY CO., LTD. (KP) | 2004-12-30 | — | — | US | disclosed |
| US-20040209117-A1 | Organic light emitting devices | XEROX CORPORATION | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209117-A1 | Organic light emitting devices | OXA1L, OCIAD1, SLCO4C1 | PTGES 4225/4885JAK2 4543/4885L3MBTL1 3964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.